{"id":"https://openalex.org/W7159667481","doi":"https://doi.org/10.51470/apr.2026.05.01.32","title":"Drug Approval Processes During Emergency Situations: Emergency UseAuthorization (Eua)","display_name":"Drug Approval Processes During Emergency Situations: Emergency UseAuthorization (Eua)","publication_year":2026,"publication_date":"2026-03-05","ids":{"openalex":"https://openalex.org/W7159667481","doi":"https://doi.org/10.51470/apr.2026.05.01.32"},"language":"en","primary_location":{"id":"doi:10.51470/apr.2026.05.01.32","doi":"https://doi.org/10.51470/apr.2026.05.01.32","is_oa":true,"landing_page_url":"https://doi.org/10.51470/apr.2026.05.01.32","pdf_url":"https://pharma.researchfloor.org/wp-content/uploads/2026/04/Drug-Approval-Processes-During-Emergency-Situations-Emergency-Use-Authorization-Eua.pdf","source":{"id":"https://openalex.org/S4404660822","display_name":"Acta Pharma Reports.","issn_l":"3041-5381","issn":["3041-5381"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharma Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://pharma.researchfloor.org/wp-content/uploads/2026/04/Drug-Approval-Processes-During-Emergency-Situations-Emergency-Use-Authorization-Eua.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076085203","display_name":"Trapti Saxena","orcid":"https://orcid.org/0000-0003-0498-2956","observed_orcids":["https://orcid.org/0000-0003-0498-2956"]},"institutions":[{"id":"https://openalex.org/I4405263311","display_name":"G. Pulla Reddy College of Pharmacy","ror":"https://ror.org/053xha254","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405263311"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Trapti Saxena","raw_affiliation_strings":["Department of Regulatory Affairs, G. Pulla Reddy College of Pharmacy, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Regulatory Affairs, G. Pulla Reddy College of Pharmacy, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4405263311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134952489","display_name":"Maleeha Masood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maleeha Masood","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5134957789","display_name":"Rudra Vaishno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rudra Vaishno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"1","first_page":"32","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.7348999977111816,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.7348999977111816,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.17239999771118164,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.040300000458955765,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emergency-use-authorization","display_name":"emergency use authorization","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.7020000219345093},{"id":"https://openalex.org/keywords/fda-regulatory-policy","display_name":"FDA regulatory policy","score":0.5210000276565552},{"id":"https://openalex.org/keywords/public-health-emergencies","display_name":"public health emergencies","score":0.9829999804496765},{"id":"https://openalex.org/keywords/pandemic-preparedness","display_name":"pandemic preparedness","score":0.781000018119812},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5559999942779541},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.6819999814033508},{"id":"https://openalex.org/keywords/vaccine-authorization","display_name":"vaccine authorization","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.6295999884605408},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.5825999975204468},{"id":"https://openalex.org/C2778137410","wikidata":"https://www.wikidata.org/wiki/Q2732820","display_name":"Government (linguistics)","level":2,"score":0.5716000199317932},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5181000232696533},{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.5023999810218811},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.46369999647140503},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.453000009059906},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4431000053882599},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.4293999969959259},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.39329999685287476},{"id":"https://openalex.org/C206345919","wikidata":"https://www.wikidata.org/wiki/Q20380951","display_name":"Resource (disambiguation)","level":2,"score":0.3885999917984009},{"id":"https://openalex.org/C2984066494","wikidata":"https://www.wikidata.org/wiki/Q428148","display_name":"Government regulation","level":3,"score":0.33390000462532043},{"id":"https://openalex.org/C3020535179","wikidata":"https://www.wikidata.org/wiki/Q6554101","display_name":"Medical device","level":2,"score":0.30979999899864197},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.30410000681877136},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.296099990606308},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2921999990940094},{"id":"https://openalex.org/C2982822547","wikidata":"https://www.wikidata.org/wiki/Q179661","display_name":"Medical treatment","level":2,"score":0.2897999882698059},{"id":"https://openalex.org/C3018838755","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Medical care","level":2,"score":0.2784999907016754},{"id":"https://openalex.org/C502991105","wikidata":"https://www.wikidata.org/wiki/Q5133849","display_name":"Clinical research","level":2,"score":0.2784000039100647},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.27730000019073486},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.2721000015735626},{"id":"https://openalex.org/C2777351106","wikidata":"https://www.wikidata.org/wiki/Q49371","display_name":"Legislation","level":2,"score":0.26109999418258667}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.51470/apr.2026.05.01.32","doi":"https://doi.org/10.51470/apr.2026.05.01.32","is_oa":true,"landing_page_url":"https://doi.org/10.51470/apr.2026.05.01.32","pdf_url":"https://pharma.researchfloor.org/wp-content/uploads/2026/04/Drug-Approval-Processes-During-Emergency-Situations-Emergency-Use-Authorization-Eua.pdf","source":{"id":"https://openalex.org/S4404660822","display_name":"Acta Pharma Reports.","issn_l":"3041-5381","issn":["3041-5381"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharma Reports","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.51470/apr.2026.05.01.32","doi":"https://doi.org/10.51470/apr.2026.05.01.32","is_oa":true,"landing_page_url":"https://doi.org/10.51470/apr.2026.05.01.32","pdf_url":"https://pharma.researchfloor.org/wp-content/uploads/2026/04/Drug-Approval-Processes-During-Emergency-Situations-Emergency-Use-Authorization-Eua.pdf","source":{"id":"https://openalex.org/S4404660822","display_name":"Acta Pharma Reports.","issn_l":"3041-5381","issn":["3041-5381"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharma Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7159667481.pdf","grobid_xml":"https://content.openalex.org/works/W7159667481.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W3027630905","https://openalex.org/W3085812475","https://openalex.org/W3165569083","https://openalex.org/W4282553966"],"related_works":["https://openalex.org/W6981440602","https://openalex.org/W2366341330","https://openalex.org/W7096994666","https://openalex.org/W2327447875","https://openalex.org/W3204089332","https://openalex.org/W3081212182","https://openalex.org/W4412064174","https://openalex.org/W4387419922","https://openalex.org/W7026390993","https://openalex.org/W4396568846"],"abstract_inverted_index":{"A":[0],"pharmaceutical":[1],"company":[2],"trying":[3],"to":[4,178],"manufacture":[5],"a":[6,129,154,173],"drug,":[7],"cosmetic,":[8],"vaccine,":[9],"or":[10,45,52,65,72,94,176],"medical":[11,92,98,123,137,174],"device":[12],"must":[13,185,194],"first":[14],"establish":[15],"its":[16,191,196],"safety":[17],"and":[18,56,125,139,156,188,190],"efficacy.":[19],"This":[20,37,83],"is":[21,148],"done":[22],"by":[23,30,133,181],"conducting":[24],"preliminary":[25],"investigations":[26],"in":[27,158],"animals,":[28],"followed":[29],"establishing":[31],"clinical":[32,35],"efficacy":[33],"through":[34],"trials.":[36],"whole":[38],"process":[39],"spans":[40],"years":[41],"before":[42],"the":[43,50,75,104,143,151,161,164,182],"FDA":[44,76,101],"other":[46],"regulatory":[47,84],"bodies":[48],"approve":[49],"drug":[51],"vaccine":[53],"for":[54,78,87,122],"marketing":[55],"distribution.":[57],"In":[58],"situations":[59],"involving":[60],"public":[61,130],"health":[62,131],"emergencies,":[63],"pandemics,":[64],"potential":[66,192,197],"threats":[67],"such":[68],"as":[69,118],"chemical,":[70],"biological,":[71],"nuclear":[73],"incidents,":[74],"allows":[77,86,103],"Emergency":[79],"Use":[80],"Authorisation":[81],"(EUA).":[82],"approach":[85],"fast-track":[88],"authorization":[89],"of":[90,97,106,163],"unapproved":[91],"products":[93,138],"unauthorized":[95],"indications":[96],"products.":[99],"The":[100,146],"also":[102],"use":[105],"EUA":[107,147],"when":[108],"there":[109],"are":[110],"no":[111],"adequate":[112],"alternative":[113],"treatment":[114,177],"options":[115],"available.EUA":[116],"acts":[117],"an":[119],"essential":[120],"resource":[121],"practitioners":[124],"healthcare":[126],"professionals":[127],"during":[128,142],"crisis":[132,155,167],"using":[134],"all":[135],"possible":[136],"treatments":[140],"available":[141],"emergency":[144],"period.":[145],"activated":[149,170],"once":[150],"government":[152],"declares":[153],"remains":[157],"effect":[159],"until":[160],"end":[162],"said":[165],"specific":[166],"it":[168,184],"was":[169],"for.":[171],"For":[172],"product":[175],"be":[179,186],"approved":[180],"EUA,":[183],"\u201csafe":[187],"effective,\u201d":[189],"benefits":[193],"outweigh":[195],"risks.":[198]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-05-02T00:00:00"}